Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|10|1173-1193

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1173-1193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hereditary Haemorrhagic Telangiectasia: A Rare Disease As A Model for the Study of Human Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 13, Iss. 36, 2007-12 ,pp. : 3656-3664

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Molecular and Clinical Aspects of Hereditary Hemorragic Telangiectasia: A Rare Disease Executive Editor: (Emilo Jirillo)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1169-1170

Bentham Science Publishers

Access to resources Recommend Favorite

Psoralens: Induction of hereditary haemorrhagic telangiectasia during concomitant ultraviolet A phototherapy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1156, 2007-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Molecular and Genetic Characteristics of Hereditary Autoinflammatory Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 77-80

Bentham Science Publishers

Access to resources Recommend Favorite

HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1217-1220

Bentham Science Publishers

Access to resources Recommend Favorite